Correlation Between Prime Medicine, and Ginkgo Bioworks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Prime Medicine, and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Ginkgo Bioworks.

Diversification Opportunities for Prime Medicine, and Ginkgo Bioworks

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Prime and Ginkgo is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between Prime Medicine, and Ginkgo Bioworks

Given the investment horizon of 90 days Prime Medicine, Common is expected to generate 0.8 times more return on investment than Ginkgo Bioworks. However, Prime Medicine, Common is 1.26 times less risky than Ginkgo Bioworks. It trades about -0.09 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.12 per unit of risk. If you would invest  650.00  in Prime Medicine, Common on August 24, 2024 and sell it today you would lose (353.00) from holding Prime Medicine, Common or give up 54.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Prime Medicine, Common  vs.  Ginkgo Bioworks Holdings

 Performance 
       Timeline  
Prime Medicine, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Prime Medicine, and Ginkgo Bioworks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prime Medicine, and Ginkgo Bioworks

The main advantage of trading using opposite Prime Medicine, and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.
The idea behind Prime Medicine, Common and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets